
|Videos|October 11, 2016
Atopic Dermatitis: Determining Utilization Management Criteria for Long-Term Systemic Therapies
Advertisement
Panelists Peter L. Salgo, MD; Jonathan Silverberg, MD, PhD, MPH; Jeffrey D. Dunn, PharmD, MBA; Cheryl Allen, BS Pharm, MBA; and Ed Pezalla, MD, MPH, discuss determining and recognizing utilization management for long-term systemic therapies in patients with atopic dermatitis.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Accepts Furosemide Autoinjector sNDA for Treatment of Edema in Chronic Kidney Disease or Chronic Heart Failure
2
FDA Approves Pirtobrutinib for Relapsed or Refractory Chronic Lymphocytic Leukemia
3
Pharmacists Can Advance Lung Cancer Screening Awareness in High-Risk Patients
4
A Closer Look at Interdisciplinary Care with Unit-Based Pharmacy
5



















































































































































































































